000 | 02003 a2200661 4500 | ||
---|---|---|---|
005 | 20250517080751.0 | ||
264 | 0 | _c20180102 | |
008 | 201801s 0 0 eng d | ||
022 | _a1538-7836 | ||
024 | 7 |
_a10.1111/jth.13291 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBleker, S M | |
245 | 0 | 0 |
_aCurrent management strategies and long-term clinical outcomes of upper extremity venous thrombosis. _h[electronic resource] |
260 |
_bJournal of thrombosis and haemostasis : JTH _c05 2016 |
||
300 |
_a973-81 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
650 | 0 | 4 | _aDecision Support Systems, Clinical |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aFibrin Fibrinogen Degradation Products _xanalysis |
650 | 0 | 4 | _aFollow-Up Studies |
650 | 0 | 4 | _aHemorrhage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 |
_aNeoplasms _xcomplications |
650 | 0 | 4 | _aPrevalence |
650 | 0 | 4 | _aRecurrence |
650 | 0 | 4 | _aRisk Factors |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aUpper Extremity Deep Vein Thrombosis _xetiology |
650 | 0 | 4 |
_aVenous Thromboembolism _xetiology |
650 | 0 | 4 |
_aVenous Thrombosis _xdrug therapy |
700 | 1 | _avan Es, N | |
700 | 1 | _aKleinjan, A | |
700 | 1 | _aBüller, H R | |
700 | 1 | _aKamphuisen, P W | |
700 | 1 | _aAggarwal, A | |
700 | 1 | _aBeyer-Westendorf, J | |
700 | 1 | _aCamporese, G | |
700 | 1 | _aCosmi, B | |
700 | 1 | _aGary, T | |
700 | 1 | _aGhirarduzzi, A | |
700 | 1 | _aKaasjager, K | |
700 | 1 | _aLerede, T | |
700 | 1 | _aMarschang, P | |
700 | 1 | _aMeijer, K | |
700 | 1 | _aOtten, H-M | |
700 | 1 | _aPorreca, E | |
700 | 1 | _aRighini, M | |
700 | 1 | _aVerhamme, P | |
700 | 1 | _avan Wissen, S | |
700 | 1 | _aDi Nisio, M | |
773 | 0 |
_tJournal of thrombosis and haemostasis : JTH _gvol. 14 _gno. 5 _gp. 973-81 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/jth.13291 _zAvailable from publisher's website |
999 |
_c25722939 _d25722939 |